Sensitivity analysis of FDA´s benchmark nozzle regarding in vitro imperfections - Do we need asymmetric CFD benchmarks?

Modern technologies and methods such as computer simulation, so-called in silico methods, foster the development of medical devices. For accelerating the uptake of computer simulations and to increase credibility and reliability the U.S. Food and Drug Administration organized an inter-laboratory rou...

Full description

Bibliographic Details
Main Authors: Stiehm Michael, Brandt-Wunderlich Christoph, Siewert Stefan, Schmitz Klaus-Peter, Grabow Niels, Goubergrits Leonid, Kühne Titus, Poon Eric K. W., Ooi Andrew, Barlis Peter
Format: Article
Language:English
Published: De Gruyter 2020-09-01
Series:Current Directions in Biomedical Engineering
Subjects:
Online Access:http://www.degruyter.com/view/j/cdbme.2020.6.issue-3/cdbme-2020-3020/cdbme-2020-3020.xml?format=INT

Similar Items